Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Nike
NKE
5
Palantir
PLTR
JP Stock MarketDetailed Quotes
4528 Ono Pharmaceutical
- 1628.5
- +61.5+3.92%
20min DelayMarket Closed Apr 4 15:30 JST
812.12BMarket Cap6.11P/E (Static)
1646.5High1610.0Low4.62MVolume1645.0Open1567.0Pre Close7.53BTurnover2464.052wk High1.21%Turnover Ratio498.69MShares1503.552wk Low157.93EPS TTM624.27BFloat Cap5880.0Historical High6.11P/E (Static)383.34MShs Float640.0Historical Low266.57EPS LYR2.33%Amplitude80.00Dividend TTM0.94P/B100Lot Size4.91%Div YieldTTM
Ono Pharmaceutical Key Stats
EPS
According to the latest financial report of Ono Pharmaceutical, the latest earnings per share (TTM) for the company is 31.81. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about Ono Pharmaceutical's free cash flow? The latest report shows it as 17.56B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Ono Pharmaceutical shows that the company's current ratio is 3.55, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Ono Pharmaceutical, the quick ratio is 2.66, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of Ono Pharmaceutical? The latest ROE figure is 1.87%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Ono Pharmaceutical, the total asset return on investment (ROA) is 1.40%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Ono Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 65.85%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Ono Pharmaceutical, the net profit margin is 11.09%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...